tiprankstipranks
Stablecoin Development Corporation (SDEV)
XASE:SDEV
Want to see SDEV full AI Analyst Report?

Stablecoin Development Corp (SDEV) Price & Analysis

803 Followers

SDEV Stock Chart & Stats

$2.95
-$0.04(-5.41%)
At close: 4:00 PM EST
$2.95
-$0.04(-5.41%)

Bulls Say, Bears Say

Bulls Say
Asset SaleNovaBay accepted an increased offer of $11.5 million for its Avenova assets, which may benefit the company's financial position.
Business StrategyThe sale of DERMAdoctor should reduce its cash burn and allows it to focus on pursuing newer and stronger growth opportunities that are better aligned with its core eyecare business.
Bears Say
Financial PerformanceNet loss was $1.6 million or EPS of $(1.37) compared with our estimates of $(1.28) and consensus of $(1.23).
Investor UncertaintyThe company did not provide 2024 guidance, which creates uncertainty for investors.
Revenue PerformanceRevenue was $2.4 million compared with our estimates of $2.8 million and consensus of $3.2 million.

SDEV FAQ

What was Stablecoin Development Corporation’s price range in the past 12 months?
Stablecoin Development Corporation lowest stock price was $1.08 and its highest was $99.75 in the past 12 months.
    What is Stablecoin Development Corporation’s market cap?
    Stablecoin Development Corporation’s market cap is $31.18M.
      When is Stablecoin Development Corporation’s upcoming earnings report date?
      Stablecoin Development Corporation’s upcoming earnings report date is Aug 06, 2026 which is in 63 days.
        How were Stablecoin Development Corporation’s earnings last quarter?
        Stablecoin Development Corporation released its earnings results on May 20, 2026. The company reported $3.334 earnings per share for the quarter, beating the consensus estimate of N/A by $3.334.
          Is Stablecoin Development Corporation overvalued?
          According to Wall Street analysts Stablecoin Development Corporation’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Stablecoin Development Corporation pay dividends?
            Stablecoin Development Corporation pays a Notavailable dividend of $0.8 which represents an annual dividend yield of N/A. See more information on Stablecoin Development Corporation dividends here
              What is Stablecoin Development Corporation’s EPS estimate?
              Stablecoin Development Corporation’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Stablecoin Development Corporation have?
              Stablecoin Development Corporation has 27,115,646 shares outstanding.
                What happened to Stablecoin Development Corporation’s price movement after its last earnings report?
                Stablecoin Development Corporation reported an EPS of $3.334 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.935%.
                  Which hedge fund is a major shareholder of Stablecoin Development Corporation?
                  Currently, no hedge funds are holding shares in SDEV
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Stablecoin Development Corp Stock Smart Score

                    Company Description

                    Stablecoin Development Corporation

                    Stablecoin Development Corp. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.

                    Stablecoin Development Corp (SDEV) Earnings & Revenues

                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Soligenix
                    Jaguar Animal Health
                    Evaxion Biotech
                    SciSparc Ltd.
                    60 Degrees Pharmaceuticals, Inc.

                    Ownership Overview

                    Currently, No data available
                    ---
                    Popular Stocks